{"id":10453,"date":"2026-05-22T22:18:00","date_gmt":"2026-05-22T20:18:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=a6eb7b5cc90644f661ace895cfc1217f"},"modified":"2026-05-22T22:18:00","modified_gmt":"2026-05-22T20:18:00","slug":"eurofins-scientific-se-director-pdmr-shareholding-2","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=10453","title":{"rendered":"Eurofins Scientific SE: Director\/PDMR Shareholding"},"content":{"rendered":"

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (\u201cPDMR\u201d). The notification of Dealing Form for each PDMR can be found below.<\/p><\/a><\/a>

\nThis notification is made in accordance with the European Market Abuse Regulation.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n

\nNOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM<\/b><\/p><\/td><\/tr>\n

\n\n\n\u00a0<\/td>\n<\/tr>\n

\n1.<\/b><\/p><\/td>

\nDetails of the person discharging managerial responsibilities\/person closely associated<\/b><\/p><\/td><\/tr>\n

\na)<\/p><\/td>

\nName<\/p><\/td>

\nLaurent Lebras<\/p><\/td><\/tr>\n

\n\u00a0<\/td>\n<\/tr>\n

\n2.<\/b><\/p><\/td>

\nReason for the notification<\/b><\/p><\/td><\/tr>\n

\na)<\/p><\/td>

\nPosition \/ status<\/p><\/td>

\nGroup CFO<\/p><\/td><\/tr>\n

\nb)<\/p><\/td>

\nInitial notification \/ amendment<\/p><\/td>

\nInitial<\/p><\/td><\/tr>\n

\n\u00a0<\/td>\n<\/tr>\n

\n3.<\/b><\/p><\/td>

\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor<\/b><\/p><\/td><\/tr>\n

\na)<\/p><\/td>

\nName<\/p><\/td>

\nEurofins Scientific S.E.<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\nb)<\/p><\/td>

\nLEI<\/p><\/td>

\n529900JEHFM47DYY3S57<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n\u00a0<\/td>\n<\/tr>\n

\n4.<\/b><\/p><\/td>

\nDetails of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted<\/b><\/p><\/td><\/tr>\n

\na)<\/p><\/td>

\nDescription of the financial instrument, type of instrument<\/p><\/td>

\nShare<\/p><\/td><\/tr>\n

\n\u00a0<\/p><\/td>

\nIdentification code<\/p><\/td>

\nISIN: FR0014000MR3<\/p><\/td><\/tr>\n

\nb)<\/p><\/td>

\nNature of the transaction<\/p><\/td>

\nExercise of stock options under the Eurofins stock option programme. Number of options exercised: 1000<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\nTransaction is linked to the Eurofins stock option \/ free share \/ stock option program<\/p><\/td><\/tr>\n

\nc)<\/p><\/td>

\nPrice(s) and volume(s)<\/p><\/td>

\nPrice(s)<\/p><\/td>

\nVolume(s)<\/p><\/td><\/tr>\n

\nn\/a<\/p><\/td>

\nn\/a<\/p><\/td><\/tr>\n

\nd)<\/p><\/td>

\nAggregated information<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n\u2014 Aggregated volume<\/p><\/td>

\n1000<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n\u2014 Price<\/p><\/td>

\n<\/tr>\n

\ne)<\/p><\/td>

\nDate of the transaction<\/p><\/td>

\n2026-05-21<\/p><\/td><\/tr>\n

\nf)<\/p><\/td>

\nPlace of the transaction<\/p><\/td>

\nOutside a trading venue<\/p><\/td><\/tr>\n

\n\u00a0<\/p><\/td><\/tr>\n

\n4.<\/b><\/p><\/td>

\nDetails of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted<\/b><\/p><\/td><\/tr>\n

\na)<\/p><\/td>

\nDescription of the financial instrument, type of instrument<\/p><\/td>

\nShare<\/p><\/td><\/tr>\n

\n\u00a0<\/p><\/td>

\nIdentification code<\/p><\/td>

\nISIN: FR0014000MR3<\/p><\/td><\/tr>\n

\nb)<\/p><\/td>

\nNature of the transaction<\/p><\/td>

\nSale of shares<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\nTransaction is linked to the Eurofins stock option \/ free share \/ stock option program<\/p><\/td><\/tr>\n

\nc)<\/p><\/td>

\nPrice(s) and volume(s)<\/p><\/td>

\nPrice(s)<\/p><\/td>

\nVolume(s)<\/p><\/td><\/tr>\n

\nEUR 62.00<\/p><\/td>

\n1000<\/p><\/td><\/tr>\n

\nd)<\/p><\/td>

\nAggregated information<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n\u2014 Aggregated volume<\/p><\/td>

\nEUR 62,000.00<\/p><\/td>

\n<\/tr>\n

\n\u2014 Price<\/p><\/td>

\nEUR 62.00<\/p><\/td><\/tr>\n

\ne)<\/p><\/td>

\nDate of the transaction<\/p><\/td>

\n2026-05-21<\/p><\/td><\/tr>\n

\nf)<\/p><\/td>

\nPlace of the transaction<\/p><\/td>

\nXPAR<\/p><\/td><\/tr>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n

\n4.<\/b><\/p><\/td>

\nDetails of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted<\/b><\/p><\/td><\/tr>\n

\na)<\/p><\/td>

\nDescription of the financial instrument, type of instrument<\/p><\/td>

\nShare<\/p><\/td><\/tr>\n

\n\u00a0<\/p><\/td>

\nIdentification code<\/p><\/td>

\nISIN: FR0014000MR3<\/p><\/td><\/tr>\n

\nb)<\/p><\/td>

\nNature of the transaction<\/p><\/td>

\nExercise of stock options under the Eurofins stock option programme. Number of options exercised: 2000<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\nTransaction is linked to the Eurofins stock option \/ free share \/ stock option program<\/p><\/td><\/tr>\n

\nc)<\/p><\/td>

\nPrice(s) and volume(s)<\/p><\/td>

\nPrice(s)<\/p><\/td>

\nVolume(s)<\/p><\/td><\/tr>\n

\nn\/a<\/p><\/td>

\nn\/a<\/p><\/td><\/tr>\n

\nd)<\/p><\/td>

\nAggregated information<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n\u2014 Aggregated volume<\/p><\/td>

\n2000<\/p><\/td>

\n<\/tr>\n

\n\u2014 Price<\/p><\/td>

\n<\/tr>\n

\ne)<\/p><\/td>

\nDate of the transaction<\/p><\/td>

\n2026-05-22<\/p><\/td><\/tr>\n

\nf)<\/p><\/td>

\nPlace of the transaction<\/p><\/td>

\nOutside a trading venue<\/p>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n

\n4.<\/b><\/p><\/td>

\nDetails of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted<\/b><\/p><\/td><\/tr>\n

\na)<\/p><\/td>

\nDescription of the financial instrument, type of instrument<\/p><\/td>

\nShare<\/p><\/td><\/tr>\n

\n\u00a0<\/p><\/td>

\nIdentification code<\/p><\/td>

\nISIN: FR0014000MR3<\/p><\/td><\/tr>\n

\nb)<\/p><\/td>

\nNature of the transaction<\/p><\/td>

\nSale of shares<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\nTransaction is linked to the Eurofins stock option \/ free share \/ stock option program<\/p><\/td><\/tr>\n

\nc)<\/p><\/td>

\nPrice(s) and volume(s)<\/p><\/td>

\nPrice(s)<\/p><\/td>

\nVolume(s)<\/p><\/td><\/tr>\n

\nEUR 63.00<\/p><\/td>

\n2000<\/p><\/td><\/tr>\n

\nd)<\/p><\/td>

\nAggregated information<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n\u2014 Aggregated volume<\/p><\/td>

\nEUR 126,000.00<\/p><\/td>

\n<\/tr>\n

\n\u2014 Price<\/p><\/td>

\nEUR 63.00<\/p><\/td><\/tr>\n

\ne)<\/p><\/td>

\nDate of the transaction<\/p><\/td>

\n2026-05-22<\/p><\/td><\/tr>\n

\nf)<\/p><\/td>

\nPlace of the transaction<\/p><\/td>

\nXPAR<\/p><\/td><\/tr>\n<\/table>

\nFor more information, please visit <\/b>www.eurofins.com<\/a>.<\/p>

\nAbout Eurofins \u2013 the global leader in bio-analysis<\/b><\/p>

\nEurofins is Testing for Life. With over 65,000 staff across a network of more than 950 laboratories in over 1,000 companies in 59 countries, Eurofins offers a portfolio of over 200,000 analytical methods.<\/p>

\nEurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.<\/p> Contacts<\/b>

\nInvestor Relations\nEurofins Scientific SE\nPhone: +32 2 766 1620\nE-mail: ir@sc.eurofinseu.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

LUXEMBOURG–(BUSINESS WIRE)–Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (\u201cPDMR\u201d). The notification of Dealing Form for each PDMR can be found below.
\nTh…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10453","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10453","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10453"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10453\/revisions"}],"predecessor-version":[{"id":10454,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10453\/revisions\/10454"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10453"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10453"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}